Holen Sie sich die Stockscreener-App
19.66
0.30%
-0.06
Handel nachbörslich:
19.01
-0.65
-3.31%
Schlusskurs vom Vortag:
$19.72
Offen:
$19.72
24-Stunden-Volumen:
926.84K
Relative Volume:
0.46
Marktkapitalisierung:
$3.00B
Einnahmen:
$205.22M
Nettoeinkommen (Verlust:
$-121.24M
KGV:
-24.15
EPS:
-0.8141
Netto-Cashflow:
$-82.81M
1W Leistung:
+5.64%
1M Leistung:
+16.33%
6M Leistung:
+114.86%
1J Leistung:
+243.11%
1-Tages-Spanne:
$19.25
$19.72
1-Wochen-Bereich:
$18.40
$20.76
52-Wochen-Spanne:
$5.69
$20.76
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
Firmenname
Adaptive Biotechnologies Corp
Sektor
Branche
Telefon
206-659-0067
Adresse
1165 EASTLAKE AVE E, SEATTLE, WA
Vergleichen Sie ADPT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
19.66 | 3.01B | 205.22M | -121.24M | -82.81M | -0.8141 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-30 | Eingeleitet | Guggenheim | Buy |
| 2025-06-18 | Eingeleitet | Craig Hallum | Buy |
| 2025-03-21 | Hochstufung | Goldman | Neutral → Buy |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-12-21 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Underperform |
| 2022-06-03 | Eingeleitet | Piper Sandler | Neutral |
| 2022-02-16 | Bestätigt | BTIG Research | Buy |
| 2022-02-16 | Bestätigt | BofA Securities | Buy |
| 2022-02-16 | Bestätigt | Goldman | Neutral |
| 2022-02-16 | Bestätigt | JP Morgan | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-03-03 | Herabstufung | Goldman | Buy → Neutral |
| 2020-10-08 | Fortgesetzt | BTIG Research | Buy |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-06-03 | Eingeleitet | Goldman | Buy |
| 2019-07-23 | Eingeleitet | BTIG Research | Buy |
| 2019-07-22 | Eingeleitet | BofA/Merrill | Buy |
| 2019-07-22 | Eingeleitet | Cowen | Outperform |
| 2019-07-22 | Eingeleitet | Goldman | Neutral |
| 2019-07-22 | Eingeleitet | Guggenheim | Buy |
| 2019-07-22 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Adaptive Biotechnologies Corp Aktie (ADPT) Neueste Nachrichten
Street Watch: Why Adaptive Biotechnologies Corporation stock remains undervaluedGlobal Markets & Weekly High Return Opportunities - BỘ NỘI VỤ
Its Stock Has Paid Off Big Time For Adaptive Biotechnologies Corp - Setenews
Sharon Benzeno Sells 308,477 Shares of Adaptive Biotechnologies (NASDAQ:ADPT) Stock - MarketBeat
Adaptive Biotechnologies’ Benzeno sells $10.1m in shares By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies’ Benzeno sells $10.1m in shares - Investing.com
[Form 4] Adaptive Biotechnologies Corp Insider Trading Activity - Stock Titan
Adaptive Biotechnologies (ADPT) Showcases clonoSEQ Test at Hemat - GuruFocus
Adaptive Biotechnologies' clonoSEQ® Test Featured in 89 Abstracts at ASH Annual Meeting 2025 - Quiver Quantitative
Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting - Yahoo Finance
Adaptive Biotechnologies (ADPT) Hits 3-Year High. Here's Why - Finviz
Adaptive Biotechnologies (ADPT) Hits 3-Year High. Here’s Why - Insider Monkey
568,090 Shares in Adaptive Biotechnologies Corporation $ADPT Acquired by Hillsdale Investment Management Inc. - MarketBeat
Adaptive Biotechnologies stock hits 52-week high at $17.89 By Investing.com - Investing.com Nigeria
Officer Benzeno Files To Sell 308,837 Of Adaptive Biotechnologies Corp [ADPT] - TradingView
ADPT Stock Sees Significant 11.3% Increase - GuruFocus
Adaptive Biotechnologies stock hits 52-week high at $17.89 - Investing.com
Check out these key findings about Adaptive Biotechnologies Corp (ADPT) - Setenews
Why Adaptive Biotechnologies Corporation (1HM) stock stays resilientWeekly Investment Report & Precise Swing Trade Entry Alerts - newser.com
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Adaptive Biotechnologies (NASDAQ:ADPT) Trading Up 6.3%Should You Buy? - MarketBeat
Is Adaptive Biotechnologies Corporation (1HM) stock a top hedge fund pickAnalyst Upgrade & Weekly High Return Forecasts - newser.com
Adaptive Biotechnologies Corp (ADPT) Stock Price, Trades & News - GuruFocus
How strong is Adaptive Biotechnologies Corporation (1HM) stock earnings growthOil Prices & Consistent Growth Equity Picks - newser.com
Is Adaptive Biotechnologies Corporation (1HM) stock safe for risk averse investorsMarket Trend Report & Risk Adjusted Buy/Sell Alerts - newser.com
Adaptive Biotechnologies at Jefferies: Strategic Growth Insights - Investing.com
Adaptive Biotechnologies at Jefferies: Strategic Growth Insights By Investing.com - Investing.com UK
Can technical indicators confirm Adaptive Biotechnologies Corporation’s reversalQuarterly Profit Summary & Short-Term Trading Alerts - newser.com
Adaptive Biotechnologies CFO Piskel sells $3343 in shares - Investing.com
CFO Piskel Surrenders 238 Of Adaptive Biotechnologies Corp [ADPT] - TradingView
Continued Momentum Lifted Adaptive Biotechnologies Corporation (ADPT) in Q3 - Yahoo Finance
Will Adaptive Biotechnologies Corporation (1HM) stock sustain uptrend momentumQuarterly Profit Review & Real-Time Stock Entry Alerts - newser.com
Non-operating income (total) of Adaptive Biotechnologies Corp. – HAM:1HM - TradingView
Evaluating Adaptive Biotechnologies Corporation with trendline analysisWeekly Trade Report & Weekly Breakout Opportunity Watchlist - newser.com
The time has not yet come to remove your chips from the table: Adaptive Biotechnologies Corp (ADPT) - Setenews
Using Ichimoku Cloud for Adaptive Biotechnologies Corporation technicals2025 Historical Comparison & AI Enhanced Trading Signals - newser.com
Adaptive Biotechnologies CEO Robins sells $1.3m in shares By Investing.com - Investing.com UK
Chad Robins Sells 89,265 Shares of Adaptive Biotechnologies Corp - GuruFocus
Adaptive Biotechnologies CEO Robins sells $1.3m in shares - Investing.com India
Adaptive Biotechnologies Executives Sell Shares Under Trading Plan - TradingView
Adaptive Biotechnologies Corporation (ADPT) Stock Price Quote Today & Current Price Chart - Capital.com
Finanzdaten der Adaptive Biotechnologies Corp-Aktie (ADPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):